$UNH · UnitedHealth Group

Thesis

UNH is riding the sharpest positive-revision cycle of the wall — Street EPS up 10.4% in 90 days to $4.12 as MCR control returns and MA plan exits (1M+ members shed) show up as an earnings tailwind. Options are pricing a 7% move. We see $4.22 EPS with a guide raise to $19.80-20.10.

What would flip it

An MCR print above 88% kills the thesis — single most-watched metric this call.

The market's narrative

The epic positive revisions cycle — Street EPS +10.4% in 90d (from $3.76 → $4.12). Q2 MCR beat (86.7% vs 89.4% YoY) proved cost control is back. FY26 guide $19.50-$20.00 is the confirming anchor. Options pricing a 7.15% move — buy-side demand for post-print direction confirmation.

Where the Street may be wrong

• Optum Health operating-earnings guide beat — Q2 trajectory suggests $2.4-2.6B vs $2.2B company guide; Optum revenue mix shift to higher-margin HBS and OptumRx wins
• MA plan exits (>1M members) — the exits themselves are an EPS tailwind (shedding negative-margin lives); Street has only partially modeled the mix benefit
• 90-day positive-revision cycle is textbook sell-side 'catch-up-to-reality' — these cycles tend to continue 1-2 quarters past the inflection; FY27 guide early-wire possible

Peer read: ELV/CI/HUM print later this month. UNH leads the group; MCR cadence read-through is sector-defining.

Reasoning

• Strongest-rec stock in the wall at 1.50 composite + 0 sell ratings. 90-day EPS revisions +10.4% is the strongest positive-revision cycle in the universe past 90d — classic hype_high setup where the bar has been raised in real time.
• Finviz tech: RSI 48.25 neutral, SMA20 +0.90%, SMA50 -2.69%, SMA200 +5.65%. Short float 1.78% (highest of the wall) — residual tail-risk hedges still on from the DOJ probe/Medicare-Advantage reserve fears earlier in year.
• Options pricing 7.15% implied move — that's a $27 range on $378 spot. Buy-side is positioning for a volatile print.
• My estimate $4.22 EPS / $111.8B rev — slim beat with FY26 guide raise ($19.80-$20.10 midpoint). MA-exit mix benefit + Optum operating leverage are the two beat sources.
• Call UP +2.5% 1d, +4.0% 3d MEDIUM conf — hype_high caps magnitude vs a hype_neutral setup, but positive-revisions-cycle continuation + guide-raise optionality supports upper-end of hype_high beat template.